10,000 participant randomized Phase 2b study will evaluate Gritstone’s self-amplifying mRNA (samRNA) vaccine candidate containing Spike...

Funding will advance pipeline of 17 existing programs and approximately 10 new starts annually Company has raised nearly $700 million in...